Plus, we’re fast approaching the U.S. deadline to impose more tariffs on Chinese goods, House Judiciary Chairman Jerry Nadler said his committee will bring articles of impeachment against Trump this week, and Morgan Stanley says this stock is set to rocket higher.
Read MoreBuy Target – $5.57 or better Sell Signal – TradersPro Sell Signal Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics based on safely metabolized and rationally targeted (SMART) linker drug discovery platform in the United States. The company’s lead product candidate is Edasalonexent, an oral small molecule […]
Read MorePlus, it’s merger Monday, Uber lost its license to operate in London, and Tesla has 200,000 preorders for its Cybertruck.
Read MoreTrade Setup Buy Target – $5.75 or better Sell Target – TradersPro Sell Signal Avadel Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, France, and Ireland. The company primarily develops FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) […]
Read MoreTrade Setup Buy Target $1.52 Sell Target $1.73 Fortress Biotech, Inc. develops and commercializes pharmaceutical and biotechnology products. It markets dermatology products, such as Targadox for acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; Ala-Scalp and Triderm, which are used for the inflammatory […]
Read MorePlus, U.K. Prime Minister Johnson is facing difficulties in getting his Brexit deal through Parliament, and Boeing is facing fresh criticism on its handling of the 737 Max scandal.
Read MoreThese 3 top picks could see major upside ahead.
Read MoreTrade Setup Buy Target $151.25 or better Sell Target – TradersPro Sell Signal McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well […]
Read MoreTrade Setup Buy Target – $2.25 or better Sell Target – TradersPro Sell Signal Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat […]
Read MoreYears ago, as I began my career as an investor, I read a book by Peter Lynch. Mr. Lynch had made his name, and his fortune, as the manager of Fidelity’s flagship Magellan fund in the late /70’s and ’80’s, and his incredible performance was one of the big reasons Magellan, at the time, was […]
Read More